Literature DB >> 3884014

Transformation and growth related changes in levels of nuclear and cytoplasmic proteins antigenically related to mammalian beta-galactoside-binding lectin.

S R Carding, S J Thorpe, R Thorpe, T Feizi.   

Abstract

Immunofluorescence and immunoblotting experiments, using a monoclonal antibody to the 13 kDa mammalian beta-galactoside-binding lectin have shown that human lymphocytes contain nuclear and cytoplasmic proteins of apparent molecular masses of 130, 80, 65 and 13 kDa that are antigenically related to the lectin and whose levels and patterns of expression change in association with transformation, or after stimulation with mitogens. These observations, together with the finding that the myeloid cell line K562 is also rich in the 130 kDa component, whereas the mature granulocytes of normal donors and of patients with chronic myeloid leukaemia are lacking in all of the immunoreactive forms, raise the possibility that this family of lectin-related proteins may be components of growth regulatory systems that are variously elicited in the transformed and stimulated cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3884014     DOI: 10.1016/s0006-291x(85)80215-1

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  Soluble bovine galactose-binding lectin. cDNA cloning reveals the complete amino acid sequence and an antigenic relationship with the major encephalitogenic domain of myelin basic protein.

Authors:  W M Abbott; A Mellor; Y Edwards; T Feizi
Journal:  Biochem J       Date:  1989-04-01       Impact factor: 3.857

Review 2.  Carbohydrates as antigenic determinants of glycoproteins.

Authors:  T Feizi; R A Childs
Journal:  Biochem J       Date:  1987-07-01       Impact factor: 3.857

3.  Evidence that the 14 kDa soluble beta-galactoside-binding lectin in man is encoded by a single gene.

Authors:  W M Abbott; T Feizi
Journal:  Biochem J       Date:  1989-04-01       Impact factor: 3.857

Review 4.  Endogenous galactoside-binding lectins: a new class of functional tumor cell surface molecules related to metastasis.

Authors:  A Raz; R Lotan
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

5.  Progress in deciphering the information content of the 'glycome'--a crescendo in the closing years of the millennium.

Authors:  T Feizi
Journal:  Glycoconj J       Date:  2000 Jul-Sep       Impact factor: 2.916

6.  Inhibition of colony formation in agarose of metastatic human breast carcinoma and melanoma cells by synthetic glycoamine analogs.

Authors:  G V Glinsky; V V Mossine; J E Price; D Bielenberg; V V Glinsky; H N Ananthaswamy; M S Feather
Journal:  Clin Exp Metastasis       Date:  1996-05       Impact factor: 5.150

7.  Endogenous lectins from cultured cells: nuclear localization of carbohydrate-binding protein 35 in proliferating 3T3 fibroblasts.

Authors:  I K Moutsatsos; M Wade; M Schindler; J L Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

8.  Detection of metastasis-associated differences for receptors of glycoconjugates (lectins) in histomorphologically unchanged xenotransplants from primary and metastatic lesions of human colon adenocarcinomas.

Authors:  H J Gabius; T Ciesiolka; E Kunze; K Vehmeyer
Journal:  Clin Exp Metastasis       Date:  1989 Sep-Oct       Impact factor: 5.150

9.  Lineage- and differentiation-dependent alterations in the expression of receptors for glycoconjugates (lectins) in different human hematopoietic cell lines and low grade lymphomas.

Authors:  S Gabius; K P Hellmann; T Ciesiolka; G A Nagel; H J Gabius
Journal:  Blut       Date:  1989-08

10.  Human thymic epithelial cells express an endogenous lectin, galectin-1, which binds to core 2 O-glycans on thymocytes and T lymphoblastoid cells.

Authors:  L G Baum; M Pang; N L Perillo; T Wu; A Delegeane; C H Uittenbogaart; M Fukuda; J J Seilhamer
Journal:  J Exp Med       Date:  1995-03-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.